Cognivue

Cognivue®’s FDA-cleared technology digitally assesses cognitive functioning.

We strive to deliver on our mission to provide cognitive assessment tools to a broad range of healthcare providers for the early detection of cognitive changes.

10/24/2025

🧠 Final Webinar in Our 5-Part Series | November 13
It all comes together here—turning peer-reviewed evidence into real-world practice with James E. Galvin, MD, MPH, Chief Scientific Officer at Cognivue.

📘 Topic:
Precision Without Complexity: Cognitive and Amyloid Risk Detection Built for Real-World Clinical Practice

This closing session integrates findings from four peer-reviewed Cognivue journal publications—covering psychometric validation, normative ranges, amyloid-risk identification using biomarker-established reference standards, and the Cognivue Amyloid Risk Measure (CARM*).

Dr. Galvin will connect the dots between research and practice, showing how Cognivue Clarity® is designed for real-world clinical workflows:
• Helping clinicians detect cognitive change earlier
• Supporting meaningful conversations with patients and caregivers
• Enabling personalized care pathways that improve outcomes

🎥 Join live or watch on demand: https://bit.ly/3JFbpF9

*patent pending

10/22/2025

Cognivue named “Top Cognitive Impairment Early Detection Solution 2025” and featured as the October Cover Story in Healthcare Tech Outlook.

Cognivue has been recognized by Healthcare Tech Outlook as the Top Cognitive Impairment Early Detection Solution for 2025, further solidifying its leadership in advancing timely cognitive assessment. To highlight the achievement, Healthcare Tech Outlook profiled Cognivue in a four-page cover story in its October issue.

“Too often, cognitive change goes unrecognized until it begins to impact daily life,” said Paul W. Estes, President and CEO of Cognivue. “Cognivue’s FDA-cleared technology is designed to give clinicians practical, objective insight earlier—helping integrate cognitive assessment into routine care. This award reflects our ongoing commitment to research, innovation, and making early detection a reality across healthcare.”

Read the full Healthcare Tech Outlook feature here: ➡️ https://bit.ly/4o1oMP0

10/20/2025

⏰ Webinar #4 is this week!
Don’t miss the next session in our 5-part series with James E. Galvin, MD, MPH, Chief Scientific Officer at Cognivue.

📘 Topic:
Establishing the Standard: Psychometric Validation and Normative Data for Cognivue Clarity® Across Diverse Populations

📅 Thursday, October 23, 2025

🎥 Register to join live or watch on demand: https://bit.ly/46aNLI7

10/17/2025

🚨 Cognivue Webinar Registration Now Open
Measuring What Matters: Integrating Cognitive Assessment into Geriatric Care Pathways

We’re honored to host Dr. Ardeshir Z. Hashmi, MD, MBA, FACP, FNAP, AGSF — Endowed Chair of Geriatric Innovation and Section Chief of the Center for Geriatric Medicine at the Cleveland Clinic — for a live expert interview on the future of cognitive assessment in geriatric care.

🔍 In this 1-hour conversation, we’ll explore:
✅ How innovation and leadership in geriatrics are moving cognitive evaluation into the standard of care
✅ The challenges of incorporating cognitive assessment into patient visits
✅ How cognitive assessment can guide better care planning and outcomes

🎙️ Speakers:
• Dr. Ardeshir Z. Hashmi — Cleveland Clinic
• Dr. Joy Siegel, EdD, MBA — Nova Southeastern University

📅 November 19, 2025 | 🕐 1 PM EST / 10 AM PST
👉 Secure your seat: https://bit.ly/3INWyYW

10/15/2025

🔔 Only 2 Weeks Away! 🔔
Don’t miss our upcoming webinar:
“Unlocking Precision Care: Integrating Cognitive Insights into Hearing Treatment Plans”

🗓️ October 29, 2025 | 🕐 1PM (EST) / 10AM (PST)

In this free 60-minute session hosted by Cognivue, our expert panel will explore practical ways to turn cognitive insights into more comprehensive hearing care—with real-world examples of referral pathways and interdisciplinary collaboration.

🎙️ Expert Panel:
• Dr. Jill Davis, AuD
• Dr. Keith Darrow, PhD, CCC-A
• Dr. Diego Cahn-Hidalgo, MD, FACP
• Dr. Joy Siegel, EdD, MBA (Moderator)

🔗 Save Your Spot: https://bit.ly/3IIPL2v

10/13/2025

🌟 Excited to share that Cognivue will be exhibiting at the American Academy of Physical Medicine and Rehabilitation (AAPM&R) Annual Assembly 2025 in Salt Lake City, UT — October 22–26!

Come visit us at Booth #1603 to learn about Cognivue Clarity®, our digital cognitive assessment device that delivers an objective and comprehensive cognitive analysis in about 10-minutes.

👋 If you're attending, stop by and say hello — we'd love to meet you and show you how our cognitive assessment works.

10/10/2025

🧠 Webinar #4 of 5 | October 23
Join us for the fourth session in our 5-part webinar series with James E. Galvin, MD, MPH, Chief Scientific Officer at Cognivue.

📘 Topic:
Establishing the Standard: Psychometric Validation and Normative Data for Cognivue Clarity® Across Diverse Populations

This webinar will provide an in-depth review of the published journal article: Cognitive Assessment with Cognivue Clarity®: Psychometric Properties and Normative Ranges in a Diverse Population. Dr. Galvin will discuss the study’s methodology, key findings, and implications for practice—highlighting how Cognivue Clarity® meets core psychometric criteria (reliability, validity, sensitivity) and how normative data, stratified by demographics, can support more precise and equitable cognitive care.

🎥 Join live or watch on demand: https://bit.ly/3JPtkZz

10/02/2025

🧠 Coming Soon: Webinar #3 of 5
What if a cognitive assessment tool could do more than measure performance—and offer new perspectives on Alzheimer’s risk informed by biomarker research?

On October 9, join James E. Galvin, MD, MPH for:
📘 From Risk to a Diagnosis: Leveraging Cognivue Clarity® to Detect Preclinical Alzheimer’s and Biomarker-Confirmed Cognitive Impairment

🎥 Register to join live or watch on demand: https://bit.ly/42e3SmO

09/29/2025

🔊 WEBINAR ALERT 🔊
“Unlocking Precision Care: Integrating Cognitive Insights into Hearing Treatment Plans”
🗓️ October 29, 2025 | 🕐 1PM (EST) / 10AM (PST)

A live, moderated discussion hosted by Cognivue on how cognition is transforming hearing care:
✔ Connect cognition & hearing care
✔ Use cognitive screening results to develop more comprehensive and effective clinical treatment plans
✔ Build referral pathways & interdisciplinary collaboration

🗣️ Meet Our Experts:
• Dr. Jill Davis, AuD
• Dr. Keith Darrow, PhD, CCC-A
• Dr. Diego Cahn-Hidalgo, MD, FACP
• Dr. Joy Siegel, EdD, MBA (Moderator)

🔗 Register Here: https://bit.ly/4pHxjrI

09/25/2025

WEBINAR ON DEMAND 🎥
Decoding Tinnitus: The Unseen Connection to Brain Health and Cognitive Decline

“When a patient comes in with tinnitus, the first thing we have to do is show that we take it seriously. Because chances are by the time they’ve made it to us, they’ve searched the Google, maybe their doctor has told them—and I've heard this from patients—there’s nothing you can do.”
—Dr. Keith Darrow, PhD, CCC-A, AuDExperts

If you missed our live Cognivue webinar, you can watch it now. Hear from leading experts as they uncover the links between tinnitus, brain health, and cognitive decline. Learn practical ways providers can better support patients living with tinnitus.

👉 On Demand Access: https://bit.ly/4mw86xx

09/22/2025

Cognivue is heading to Washington, DC! 🎉
We’re excited to be exhibiting at the AuDacity 2025 Conference, hosted by the Academy of Doctors of Audiology (ADA), taking place September 25–28, 2025.

📍 Find us at Booth #520 to learn how Cognivue Thrive® can support your patients by screening for cognitive impairment and helping you highlight the strong connection between hearing and cognition.

We look forward to connecting with audiologists who are advancing hearing care and patient wellness. Stop by, say hello, and see how cognitive screening can be a value-add for your practice!

09/19/2025

🧠 Webinar #3 of 5 | October 9
Join us for the third session in our exclusive 5-part webinar series with James E. Galvin, MD, MPH, Chief Scientific Officer at Cognivue.

📘 Topic:
From Risk to a Diagnosis: Leveraging Cognivue Clarity® to Detect Preclinical Alzheimer’s and Biomarker-Confirmed Cognitive Impairment

This 1-hour webinar will present and discuss two Cognivue-led research findings derived from the Bio-Hermes Study that highlight the role of Cognivue Clarity® in detecting cognitive decline associated with underlying Alzheimer’s pathology. Dr. Galvin will examine how Cognivue Clarity’s computerized cognitive assessment, powered by adaptive psychophysics, can enhance early identification and differentiation of at-risk individuals.

🎯 Learning Highlights:
• Review data from the Bio-Hermes Study demonstrating Cognivue Clarity’s ability to detect preclinical Alzheimer’s disease and amyloid status
• Examine findings supporting the use of Cognivue Clarity in identifying individuals with biomarker-confirmed Mild Cognitive Impairment (MCI) and Alzheimer’s disease
• Understand how adaptive psychophysics enables sensitive, repeatable cognitive assessment across disease stages
• Consider how Cognivue Clarity may inform clinical workflows and support earlier recognition of cognitive changes

🎥 Join live or watch on demand: https://bit.ly/4mUV0Ly

Address

7911 Rae Boulevard
Victor, NY
14564

Telephone

+15852031969

Website

https://www.cognivue.com/

Alerts

Be the first to know and let us send you an email when Cognivue posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Cognivue:

Shortcuts

Want your practice to be the top-listed Clinic in Victor?

A Path to Cognitive Health and Peace of Mind

Cognivue® is the world’s first FDA-cleared test of cognitive function. Cognivue objectively, quantitatively and reliably identifies changes in cognitive function that could be indicative of an impairment that you may optimally treat or manage. It’s personalized, consistent and reliable.